Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.
Product portfolio:
It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.
The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.
It has two manufacturing facilities in Indore, Madhya Pradesh.
Competitive Strengths
| Period Ended | 30 Nov 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 65.17 | 39.12 | 19.53 | 17.57 |
| Total Income | 28.63 | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 8.66 | 9.79 | 2.50 | 0.33 |
| EBITDA | 13.45 | 15.21 | 5.63 | 1.70 |
| NET Worth | 17.12 | 14.73 | 4.94 | 2.44 |
| Reserves and Surplus | 7.94 | 5.55 | 4.84 | 2.34 |
| Total Borrowing | 38.17 | 15.01 | 10.49 | 9.61 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment of loan | 6.50 |
| 2 | Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises | 28.50 |
| 3 | General Corporate Purposes | |
| Total | 35.00 |
| KPI | Nov 30, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 54.41% | 99.59% |
| ROCE | 23.22% | 48.20% |
| Debt/Equity | 2.23 | 1.02 |
| RoNW | 54.41% | 99.59% |
| PAT Margin | 30.35% | 25.64% |
| EBITDA Margin | 47.11% | 39.83% |
| Price to Book Value | 8.66 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 10.67 | 10.33 |
| P/E (x) | 13.03 | 13.45 |
| IPO Date | 21 to 25 May, 2026 |
| Listing Date | Fri, May 29, 2026 |
| Face Value | ₹10 per share |
| Price Band | ₹132 to ₹139 |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 37,72,000 shares (agg. up to ₹52 Cr) |
| Reserved for Market Maker | 1,89,000 shares (agg. up to ₹3 Cr) |
| Fresh Issue (Ex Market Maker) | 32,06,000 shares (agg. up to ₹45 Cr) |
| Offer for Sale | 3,77,000 shares of ₹10 (agg. up to ₹5 Cr) |
| Net Offered to Public | 35,83,000 shares (agg. up to ₹50 Cr) |
| Share Holding Pre Issue | 91,80,001 shares |
| Share Holding Post Issue | 1,25,75,001 shares |
Mr. Mukesh Mehta and Mr. Pradeep Mehta are the company promoters.
| Share Holding Pre Issue | 99.99% |
| Share Holding Post Issue |
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.
Last Updated on June 23, 2026 CSM Technologies Ltd. IPO Incorporated in 1998, CSM Technologies is one of the few IT solution providers that have delivered unique projects for both
Last Updated on June 23, 2026 Waterways Leisure Tourism Ltd. IPO Incorporated in November 2020, Waterways Leisure Tourism Limited is one of India’s leading domestic ocean cruise operators, offering luxury
Last Updated on June 20, 2026 Advit Jewels Ltd. IPO Incorporated in 2019, Advit Jewels is a Jaipur-based jewellery company, specializing in handcrafted fine jewellery, with expertise in Kundan, Polki, Diamond
You can contribute as little as
100, 200, 500 & so…
every bit counts.
